Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

CIK: 0001703031 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value ($000): $196,868 (100.0% shares, 0.0% debt)

Holdings (5)

— DICERNA PHARMACEUTICALS INC 58.6%

Value ($000) $115,451 Shares 7,330,237 Est. Cost $9.03 Unrealized —

REPL REPLIMUNE GROUP INC 21.1%

Value ($000) $41,619 Shares 2,838,968 Est. Cost $17.53 Unrealized -17.5%

— MARINUS PHARMACEUTICALS INC 10.6%

Value ($000) $20,927 Shares 5,042,735 Est. Cost $7.04 Unrealized —

— SOLID BIOSCIENCES INC 5.8%

Value ($000) $11,439 Shares 1,989,444 Est. Cost $7.50 Unrealized —

— APTINYX INC 3.8%

Value ($000) $7,432 Shares 2,225,092 Est. Cost $24.17 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	DICERNA PHARMACEUTICALS INC	7,330,237	$115,451	58.6%	$9.03	—	COM	253031108
REPL	REPLIMUNE GROUP INC	2,838,968	$41,619	21.1%	$17.53	-17.5%	COM	76029N106
—	MARINUS PHARMACEUTICALS INC	5,042,735	$20,927	10.6%	$7.04	—	COM	56854Q101
—	SOLID BIOSCIENCES INC	1,989,444	$11,439	5.8%	$7.50	—	COM	83422E105
—	APTINYX INC	2,225,092	$7,432	3.8%	$24.17	—	COM	03836N103